These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
528 related articles for article (PubMed ID: 32520599)
1. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era. Frank S; Capriotti J; Brown SM; Tessema B Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446 [TBL] [Abstract][Full Text] [Related]
3. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic. Khan MM; Parab SR; Paranjape M Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894 [TBL] [Abstract][Full Text] [Related]
4. Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic. Chorney SR; Rizzi MD; Dedhia K Am J Otolaryngol; 2020; 41(6):102737. PubMed ID: 32979667 [TBL] [Abstract][Full Text] [Related]
5. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse. Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851 [TBL] [Abstract][Full Text] [Related]
6. Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery. Parhar HS; Tasche K; Brody RM; Weinstein GS; O'Malley BW; Shanti RM; Newman JG Head Neck; 2020 Jun; 42(6):1268-1272. PubMed ID: 32333619 [TBL] [Abstract][Full Text] [Related]
7. Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework. Naqvi SHS; Citardi MJ; Cattano D; Ostrosky-Zeichner L; Knackstedt MI; Karni RJ J Otolaryngol Head Neck Surg; 2020 Oct; 49(1):77. PubMed ID: 33109269 [TBL] [Abstract][Full Text] [Related]
8. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses. Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B J Prosthodont; 2020 Aug; 29(7):599-603. PubMed ID: 32608097 [TBL] [Abstract][Full Text] [Related]
9. Use of oral antiseptics for SARS-CoV-2 infection. Palop Larrea V; Hernández Rodríguez MÁ Med Clin (Barc); 2020 Nov; 155(9):416-417. PubMed ID: 32778429 [No Abstract] [Full Text] [Related]
10. 0.5% povidone iodine irrigation in otorhinolaryngology surgical practice during COVID 19 pandemic. Khan MM; Parab SR Am J Otolaryngol; 2020; 41(6):102687. PubMed ID: 32861125 [No Abstract] [Full Text] [Related]
11. In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2. Frank S; Brown SM; Capriotti JA; Westover JB; Pelletier JS; Tessema B JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1054-1058. PubMed ID: 32940656 [TBL] [Abstract][Full Text] [Related]
12. A Review of Topical Povidone-iodine to Decrease Viral Load of COViD-19. Benson KM; Mancini AA; Brodeur MR Sr Care Pharm; 2021 May; 36(5):238-241. PubMed ID: 33879284 [TBL] [Abstract][Full Text] [Related]
13. COVID-19: Ophthalmic prophylactic and therapeutic measures. Waikar S; Oli A Indian J Ophthalmol; 2020 Jun; 68(6):1223-1224. PubMed ID: 32461492 [No Abstract] [Full Text] [Related]
14. Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV. Sarma P; Kaur H; Medhi B; Bhattacharyya A Graefes Arch Clin Exp Ophthalmol; 2020 Nov; 258(11):2563-2565. PubMed ID: 32436084 [No Abstract] [Full Text] [Related]
15. Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection. Burton MJ; Clarkson JE; Goulao B; Glenny AM; McBain AJ; Schilder AG; Webster KE; Worthington HV Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013626. PubMed ID: 32936949 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them. Burton MJ; Clarkson JE; Goulao B; Glenny AM; McBain AJ; Schilder AG; Webster KE; Worthington HV Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013627. PubMed ID: 32936948 [TBL] [Abstract][Full Text] [Related]
17. A Surgical Protocol to Mitigate the SARS-CoV-2 Transmission Using Multifocal Povidone-Iodine Applications in Lacrimal Surgeries During Coronavirus Disease 2019 (COVID-19) Pandemic. Ali MJ Ophthalmic Plast Reconstr Surg; 2020; 36(4):416-417. PubMed ID: 32496394 [No Abstract] [Full Text] [Related]
18. Povidone-iodine functionalized nanofibers are prophylactic and protect against dissemination of SARS-CoV-2 infection. Amler E; Vojáček V; Sopko B; Divín R; Pashchenko A; Varga J; Nečas A; Celer V; Filipejova Z; Urbanová L; Rulc J; Krajníková M; Jarošíková T Epidemiol Mikrobiol Imunol; 2024; 73(2):98-105. PubMed ID: 39060100 [TBL] [Abstract][Full Text] [Related]
19. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse. Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566 [TBL] [Abstract][Full Text] [Related]
20. Virucidal effect of povidone-iodine against SARS-CoV-2 Wang Y; Wu Y; Wang Q; Zhu J; Shi W; Han Z; Zhang Y; Chen K J Int Med Res; 2021 Dec; 49(12):3000605211063695. PubMed ID: 34914884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]